The U.S. Food and Drug Administration (FDA) recently announced that Xymogen, a nutraceutical company based in Orlando, Florida, has recalled Atriphen, a product marketed for the support of healthy joint function. The recall was issued due to the presence of undeclared soy and milk allergens.
Xymogen has discontinued the sale of Atriphen. The product is being tested by a third-party laboratory to confirm the presence of soy and milk allergens.
The company warned that people who are allergic or sensitive to soy or milk may experience a serious or life-threatening reaction if they consume this product. No allergic reactions or side effects have been reported as a result of these undeclared allergens, but Xymogen is urging consumers to return the product for a full refund.
Consumers should contact the company through www.xymogen.com for comments or inquiries.
The FDA encourages consumers and health professionals to report any side effects caused by the use of Atriphen to the FDA's MedWatch Safety Information and Adverse Event Reporting Program.
For more information about food allergy, please visit Natural Standard's Medical Conditions Database.
The information in this brief report is intended for informational purposes only, and is meant to help users better understand health concerns. This information should not be interpreted as specific medical advice. Users should consult with a qualified healthcare provider for specific questions regarding therapies, diagnosis and/or health conditions, prior to making therapeutic decisions. Copyright © 2017 Natural Medicines Inc. Commercial distribution or reproduction prohibited. Natural Medicines is the leading provider of high-quality, evidence-based, clinically-relevant information on natural medicine, dietary supplements, herbs, vitamins, minerals, functional foods, diets, complementary practices, CAM modalities, exercises and medical conditions. Monograph sections include interactions with herbs, drugs, foods and labs, contraindications, depletions, dosing, toxicology, adverse effects, pregnancy and lactation data, synonyms, safety and effectiveness.